Part 1 | Part 2
Well, there’s a great debate about legalization of Marijuana (Cannabis) more commonly known as Delta-9-THC, between the proponents and the opponents many of which have netted exceptional public attention over the past couple of years in the wake of legalization of Marijuana for both medicinal and recreational purposes. Going deeper into it would be straying out of scope of this article.
I still believe there is a lot of misinformation on Marijuana (Cannabis) concerning the medicinal properties of this plant, before it could be debated you need to be educated, I very much recommend for those who are interested to know more must take some time out and watch this documentary after which you will realize that there is nothing to debate concerning the medicinal value of Cannabis.
Will it change the world like penicillin did in the past century as Mengel wants you to believe? Will the current crop of these stocks be looked as the” “next Merck” or the “next Pfizer?
I have serious apprehensions while some of them are real companies. Many of the contenders to the Marijuana legalization boom will not survive the decade. Since such stock manias pass on all the scammers into the realm of investment fad. Scammers who churn out dummy companies to naïve speculators. We have seen some of these as you might remember. It’s really hard to get a reasonable valuation for such stocks.
Health issues are involved in addition to legal issues, companies are going to be mired with multi-million dollar laws suits which can be expected for marijuana stocks as well. This is going the way of tobacco and alcohol stocks. Law suits can be brought up by the family of those who have lost its members to cardiovascular diseases, respiratory diseases and lung cancer.
I agree a few warnings notes on the bottles of the drug will do the trick to protect the companies associated with the cannabis industry, and I haven’t heard any liquor producer or a brewery going bust due to law suits, given the prosperous history of alcohol and cigarette industry.
However it’s eventually the fed that benefits from Legalization of marijuana for recreational purposes as well; legalization would provide top-down economic improvements, in state coffers. Apart from bringing in funds, it would save regional and state governments huge sums in wasted law implementation dollars.
I could see the potential growth in marijuana sales for recreational purposes because of the understandable legal demand. I am not sure if that translates to Pharmacy companies who manufacture products that are derived from marijuana or Delta-9-THC which has been legal for medical purposes for decades and in the markets in generic form.
Investing in over hyped Delta 9 stocks doesn’t make a compelling case for me I anticipate most of them are at risk of a complete failure it’s an investment fad that will go down with time, so make sure you research these stocks well before you invest in the speculation.
You have been amply warned I am sure. I haven’t gone off-track – so what was it we were looking for?
Oh yes Jimmy Mengel’s Delta 9 stocks.
A few hints from the ad
Delta-9′ Stock #1 — Potential Profit: 1,000%
This Arizona-based company is developing a range of ‘Delta-9′ drugs.
For example, it has used ‘Delta-9′ to develop a spray that helps treats multiple sclerosis symptoms, cancer pain, and neuropathic pain.
And it has a bunch of new medicines in the pipeline that will help treat epilepsy, schizophrenia, and diabetes.
Its medicine for epilepsy could be a huge seller if approved. Epilepsy affects over 50 million people globally, and current drug therapies are ineffective at treating 30% of epilepsy patients.
This is GWPH for sure as you might know it is a much loved stock for most of the speculators and newsletter vendors out there – for it’s the only game in town for a safe Cannabis Plays in US markets, others are only for the money you can afford to lose. It is very difficult to find reputable companies in the Cannabis sector.
GW Pharmaceuticals “Sativex” is the cannabinoid drug for the treatment of multiple sclerosis spasticity and cancer pain, has been flag-ship product for the sector in whole, with approvals in more than 20 countries and in Phase 3 trials with the FDA in USA they seem to be targeting approval later this year. That’s trivial for a $ billion company a tenfold increase in your bottom line as Mengel wants you to believe.
I stumbled upon this article by Nick Cox on seeking alpha while researching this write-up. For those of you who are interested to know more about it you can follow the link.
And about the other two stocks. – A few hints from the ad …
Delta-9′ Stock #2 — Potential Profit: 200%
This next company out of Chicago has developed a ‘Delta-9′ based drug that’s used for the treatment of nausea in patients undergoing chemotherapy and that’s also prescribed to AIDS patients suffering from loss of appetite.
The best part is this drug has already received FDA approval.
Since going public in late 2010, this stock has… more than doubled… and returned twice as much the S&P 500 index.
There could be only one contender to this, company that’s selling THC or a synthetic cannabinoid for nausea in cancer and aids patients is the Abbott spinoff that now sells Marinol, (ABBV). Investing in Abbott back in 2010 would have made you good returns but that wasn’t because of Marinol. Marinol is being sold for the last 30 years, and it’s not a blockbuster drug by any standard. Though (ABBV) is a bit expensive it’s not a pure Marijuana play, even though it sells synthetic cannabinoid.
I personally won’t buy into double your investment by investing in (ABBV) idea by Jimmy Mengel.
And few hints for the third and last stock
Delta-9′ Stock #3 — Potential Profit: 2,900%
It’s the smallest stock in our group… but it’s also the most undervalued, and so it’s the one that offers the greatest potential.
The Vancouver-based company has developed over 60 different varieties of ‘Delta-9.’
And it has over 60 years of experience in the pharmaceutical industry, so it’s not some fly-by-night operation.
That’s why Canada has recently licensed the company as one of the first distributers and manufacturers of ‘Delta-9.
As CBC News reports, ‘the profit potential is enormous.’
Industry experts project the ‘Delta-9′ market will grow from 40,000 individuals to 1 million in just a few years.
That’s a whopping 2,400% gain!
And this firm is a ‘pure play’ on this tremendous market growth.
A promise of 2900% gain for a small company is an overstatement by any standard perhaps this is one of those that everyone loved when the Marijuana legalization boom started. The Canadian connection in the ad is an inkling to it, beware such stocks could go both ways or completely vanish they are generally unpredictable.
By the clues outlined this seems to be a pure Canadian Marijuana play, and this reminds me of the funny analogy that occurred when marijuana legalization wave crested as an investment craze. Almost all the stocks with “cannabis” or “marijuana” in their name went up by leaps and bounds that’s how the markets behave.
A little Google’ing on the stock would reveal that this is T-bird Pharma, it’s a publicly traded Canadian enterprise that owns Thunderbird Biomedical, thanks to a reverse merger with Firebird Energy, T-bird Pharma came into existence which enabled them to go public they didn’t do anything for the marvelous gain they had on the markets. T-bird Pharma was indeed licensed as a marijuana producer by Health Canada.
If you feel I am missing out on something. Or you have better ideas in the“Delta-9″ space, use the comment box below to let us know — I would love to hear from you.
Disclosure: I don’t have any positions in any stocks mentioned herein, and no plans to initiate any in the next 72 hours.